NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Structura Biotechnology Inc.

Structura Biotechnology Inc.

Private
TorontoHealthcare & Life Scienceshttps://structura.bio/

Company Overview

Structura Biotechnology Inc. is a biotechnology company that develops a cryo-electron microscopy (cryo-EM) image analysis software platform using machine learning to help researchers and pharmaceutical companies determine the 3D atomic structures of proteins and other biological molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Hardware + Subscription

AI Layer

Application

Keywords

cryo-electron microscopycryo-EMstructural biologyprotein structure determinationdrug discovery3D reconstructionsingle-particle analysisscientific softwareAI drug discoverycomputational biologybiotech softwarereal-time data processingGPU-accelerated computingfreemium modelmedical imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Structura Biotechnology Inc. Comparables

Compare Structura Biotechnology Inc. with similar companies based on industry and business-model similarity.

Structura Biotechnology Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CryoCloud
83%
Ligo Analytics, Inc.
79%
Intellicule
73%

Structura Biotechnology Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Ali Punjani

CEO & Co-Founder

Founding Team

Saara Virani

Chief Operating Officer

Executive Team

Suhail Dawood

Chief Product Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2025

    Grew 20% QoQ, from 15 to 18 employees.

  • Oct 19, 2023

    Grew 25% QoQ from 12 to 15 employees.

Structura Biotechnology Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Structura Biotechnology Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Structura Biotechnology Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range19
Year Founded2016
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.